泰地罗新注射液体外抑菌试验及对感染副猪嗜血杆菌仔猪的保护作用

李国基,闫超群,麻雨桥,谢顺,顾欣,曹莹,黄士新,黄显会

Antibacterial Activity in Vitro and Protection of Tildipirosin Injection Against Artificially Infected Haemophilus Paracoides in Piglets

GuoJi LI,ChaoQun YAN,YuQiao MA,Shun XIE,Xin GU,Ying CAO,ShiXin HUANG,XianHui HUANG

表6 试验期间各剂量组体重变化（$\bar{X}$±S.D）

Table 6 Weight change in each dose group during the trial ($\bar{X}$±S.D)

组别 Groups 试验前体重 Pretrial weight (kg) 试验后体重 Posttest weigh (kg) 增重 Weight increment (kg) 健康对照组 Healthy control group 12.5±0.6 15.5±0.7 3.0±0.2a 泰地罗新高剂量组 High dose group of Tildipirosin injection 12.9±0.9 15.8±1.2 2.9±0.3a 泰地罗新中剂量组 Middle dose group of Tildipirosin injection 12.9±1.1 15.7±1.2 2.9±0.2a 泰地罗新低剂量组 Low dose group of Tildipirosin injection 12.7±0.9 15.2±0.9 2.5±0.2b 泰拉霉素注射液 Tulathromycin injection 13.1±0.5 16.1±0.6 3.0±0.2a 感染对照组 Infective control group 12.5±0.6 14.6±0.7 2.1±0.1c